Welcome to your Weekly Dose of Health Tech Innovation!
Stay ahead with the latest breakthroughs revolutionizing healthcare—from AI diagnostics to remote care solutions.
We bring you expert-curated insights, emerging trends, and must-know updates from the digital health frontier.
Whether you’re a clinician, innovator, or health tech enthusiast, this roundup delivers what matters most.
Let’s dive into the future of health, one innovation at a time.
Wells Fargo Appoints Tim Ruby to Lead Key Banking Division
Wells Fargo & Company announced that Tim Ruby has been appointed division executive for healthcare, higher education, and not-for-profit banking across the country. Ruby, who will be based in Chicago, will report to Phil Smith, vice chair of Specialized Industries in Commercial Banking. He replaces Bill Morgan, who retired after a 40-year career in financial services.
World First: CorWave’s Undulating Membrane Heart Pump Implanted in First Patient
CorWave, a medical device company, announces the world’s first implantation in a patient of its Left Ventricular Assist System (LVAS), the first heart pump based on breakthrough wave membrane technology. The procedure was performed by the team at St Vincent’s Hospital in Sydney, Australia. This implantation represents a major technological milestone in the field of durable mechanical circulatory support, 27 years after the first use of a durable rotary pump – a technology that has since become the standard of care.
Jazz Pharmaceuticals Names Renee Gala as President and Chief Executive Officer
Jazz Pharmaceuticals announced that the Jazz Board of Directors has unanimously selected Renee Gala, Jazz’s President and Chief Operating Officer, as the President and Chief Executive Officer, when she will also join the Board. She will succeed co-founder, Chairperson and CEO Bruce Cozadd, who informed the Board in December 2024 of his intent to retire as CEO upon the identification of the Company’s next leader. This appointment reflects a key milestone in the Board’s long-term succession planning process and previously disclosed CEO transition.
FluidAI Gets $2Million to Scale AI Postoperative Care Tech
The Government of Canada announced $2 million in funding to FluidAI Medical (FluidAI) through the Federal Economic Development Agency for Southern Ontario (FedDev Ontario), as part of a broader investment aimed at supporting Waterloo Region businesses.
Tandym Group Acquires Entitech to Boost Health Technology
Tandym Group, the leader in specialized solutions for the healthcare, life sciences, technology and professional services industries, announced its acquisition of Entitech Solutions, a leading provider of tailored solutions for healthcare and life sciences organizations.
SkylineDx’s Merlin CP-GEP Test Proven Accurate for SLNB Selection
SkylineDx announced that an independent meta-analysis has confirmed the performance of its Merlin CP-GEP assay in correctly stratifying melanoma patients for sentinel lymph node biopsy (SLNB). This unbiased analysis verifies the test to enable clinicians to select patients who can safely avoid the invasive SLNB procedure, reducing unnecessary operations and their associated risks.
Phil Secures $60Million Growth Capital from K2 HealthVentures to Boost AI Integration
Phil, a leading software-driven pharmaceutical commercialization platform, announced a $60 million growth debt financing from K2 HealthVentures, a healthcare and life sciences-focused investment firm. The funding will accelerate the integration of artificial intelligence across Phil’s platform and support continued customer expansion across a broad range of therapeutic areas.
To share your insights, please write to us at sudipto@intentamplify.com
